Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 39 studies | 52% ± 20% | |
endothelial cell | 26 studies | 30% ± 11% | |
fibroblast | 26 studies | 33% ± 18% | |
plasmacytoid dendritic cell | 17 studies | 33% ± 13% | |
myeloid cell | 15 studies | 37% ± 19% | |
endothelial cell of lymphatic vessel | 13 studies | 33% ± 12% | |
platelet | 10 studies | 30% ± 11% | |
epithelial cell of proximal tubule | 7 studies | 63% ± 12% | |
mesothelial cell | 7 studies | 36% ± 15% | |
connective tissue cell | 7 studies | 24% ± 7% | |
endothelial cell of vascular tree | 7 studies | 23% ± 7% | |
alveolar macrophage | 6 studies | 54% ± 13% | |
microglial cell | 6 studies | 25% ± 5% | |
conventional dendritic cell | 6 studies | 21% ± 3% | |
dendritic cell | 6 studies | 28% ± 14% | |
monocyte | 5 studies | 36% ± 18% | |
capillary endothelial cell | 5 studies | 26% ± 6% | |
vein endothelial cell | 5 studies | 22% ± 4% | |
epithelial cell | 5 studies | 38% ± 16% | |
mononuclear phagocyte | 4 studies | 42% ± 15% | |
glomerular endothelial cell | 4 studies | 42% ± 7% | |
megakaryocyte | 4 studies | 37% ± 14% | |
adventitial cell | 4 studies | 24% ± 8% | |
podocyte | 3 studies | 35% ± 17% | |
endothelial cell of artery | 3 studies | 29% ± 2% | |
leukocyte | 3 studies | 28% ± 6% | |
abnormal cell | 3 studies | 36% ± 14% | |
classical monocyte | 3 studies | 36% ± 19% | |
tissue-resident macrophage | 3 studies | 52% ± 4% | |
Mueller cell | 3 studies | 25% ± 11% | |
retinal cone cell | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 17559.92 | 89 / 89 | 98% | 156.07 | 879 / 901 |
breast | 100% | 10598.36 | 459 / 459 | 96% | 35.70 | 1068 / 1118 |
intestine | 100% | 5327.11 | 965 / 966 | 91% | 27.72 | 478 / 527 |
lung | 100% | 11537.75 | 578 / 578 | 87% | 26.11 | 1010 / 1155 |
skin | 88% | 9042.77 | 1600 / 1809 | 98% | 57.95 | 462 / 472 |
thymus | 100% | 5395.86 | 650 / 653 | 80% | 14.51 | 486 / 605 |
pancreas | 81% | 2195.80 | 266 / 328 | 94% | 34.32 | 168 / 178 |
prostate | 91% | 2822.18 | 223 / 245 | 83% | 15.79 | 419 / 502 |
bladder | 100% | 5818.38 | 21 / 21 | 73% | 24.12 | 367 / 504 |
ovary | 100% | 5044.32 | 180 / 180 | 70% | 14.65 | 301 / 430 |
adrenal gland | 100% | 20595.58 | 258 / 258 | 67% | 45.97 | 155 / 230 |
stomach | 69% | 2458.50 | 247 / 359 | 92% | 31.07 | 264 / 286 |
uterus | 99% | 4530.95 | 169 / 170 | 53% | 15.08 | 243 / 459 |
esophagus | 76% | 3720.36 | 1104 / 1445 | 72% | 16.32 | 132 / 183 |
brain | 17% | 335.18 | 450 / 2642 | 84% | 19.38 | 591 / 705 |
adipose | 100% | 15283.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 9561.28 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 5939.52 | 1321 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 28.30 | 79 / 80 |
liver | 23% | 567.27 | 53 / 226 | 58% | 17.45 | 235 / 406 |
lymph node | 0% | 0 | 0 / 0 | 79% | 15.88 | 23 / 29 |
heart | 79% | 2142.98 | 676 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 56% | 9.90 | 25 / 45 |
muscle | 36% | 957.53 | 291 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 8% | 174.64 | 72 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032349 | Biological process | positive regulation of aldosterone biosynthetic process |
GO_0006898 | Biological process | receptor-mediated endocytosis |
GO_0035026 | Biological process | leading edge cell differentiation |
GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_2000860 | Biological process | positive regulation of aldosterone secretion |
GO_2000643 | Biological process | positive regulation of early endosome to late endosome transport |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0045807 | Biological process | positive regulation of endocytosis |
GO_0060391 | Biological process | positive regulation of SMAD protein signal transduction |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_1902074 | Biological process | response to salt |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0048268 | Biological process | clathrin coat assembly |
GO_0010977 | Biological process | negative regulation of neuron projection development |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_2000096 | Biological process | positive regulation of Wnt signaling pathway, planar cell polarity pathway |
GO_0060766 | Biological process | negative regulation of androgen receptor signaling pathway |
GO_0010718 | Biological process | positive regulation of epithelial to mesenchymal transition |
GO_0006915 | Biological process | apoptotic process |
GO_0048545 | Biological process | response to steroid hormone |
GO_0015031 | Biological process | protein transport |
GO_1903077 | Biological process | negative regulation of protein localization to plasma membrane |
GO_1900026 | Biological process | positive regulation of substrate adhesion-dependent cell spreading |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_2000370 | Biological process | positive regulation of clathrin-dependent endocytosis |
GO_0032091 | Biological process | negative regulation of protein binding |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0030136 | Cellular component | clathrin-coated vesicle |
GO_0001650 | Cellular component | fibrillar center |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005905 | Cellular component | clathrin-coated pit |
GO_0030665 | Cellular component | clathrin-coated vesicle membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0038024 | Molecular function | cargo receptor activity |
GO_0046332 | Molecular function | SMAD binding |
GO_0050750 | Molecular function | low-density lipoprotein particle receptor binding |
GO_0035615 | Molecular function | clathrin adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DAB2 |
Protein name | Disabled homolog 2 (Adaptor molecule disabled-2) (Differentially expressed in ovarian carcinoma 2) (DOC-2) (Differentially-expressed protein 2) DAB adaptor protein 2 |
Synonyms | DOC2 |
Description | FUNCTION: Adapter protein that functions as a clathrin-associated sorting protein (CLASP) required for clathrin-mediated endocytosis of selected cargo proteins. Can bind and assemble clathrin, and binds simultaneously to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) and cargos containing non-phosphorylated NPXY internalization motifs, such as the LDL receptor, to recruit them to clathrin-coated pits. Can function in clathrin-mediated endocytosis independently of the AP-2 complex. Involved in endocytosis of integrin beta-1; this function seems to redundant with the AP-2 complex and seems to require DAB2 binding to endocytosis accessory EH domain-containing proteins such as EPS15, EPS15L1 and ITSN1. Involved in endocytosis of cystic fibrosis transmembrane conductance regulator/CFTR. Involved in endocytosis of megalin/LRP2 lipoprotein receptor during embryonal development. Required for recycling of the TGF-beta receptor. Involved in CFTR trafficking to the late endosome. Involved in several receptor-mediated signaling pathways. Involved in TGF-beta receptor signaling and facilitates phosphorylation of the signal transducer SMAD2. Mediates TFG-beta-stimulated JNK activation. May inhibit the canoniocal Wnt/beta-catenin signaling pathway by stabilizing the beta-catenin destruction complex through a competing association with axin preventing its dephosphorylation through protein phosphatase 1 (PP1). Sequesters LRP6 towards clathrin-mediated endocytosis, leading to inhibition of Wnt/beta-catenin signaling. May activate non-canonical Wnt signaling. In cell surface growth factor/Ras signaling pathways proposed to inhibit ERK activation by interrupting the binding of GRB2 to SOS1 and to inhibit SRC by preventing its activating phosphorylation at 'Tyr-419'. Proposed to be involved in modulation of androgen receptor (AR) signaling mediated by SRC activation; seems to compete with AR for interaction with SRC. Plays a role in the CSF-1 signal transduction pathway. Plays a role in cellular differentiation. Involved in cell positioning and formation of visceral endoderm (VE) during embryogenesis and proposed to be required in the VE to respond to Nodal signaling coming from the epiblast. Required for the epithelial to mesenchymal transition, a process necessary for proper embryonic development. May be involved in myeloid cell differentiation and can induce macrophage adhesion and spreading. May act as a tumor suppressor. . |
Accessions | D6RGZ1 ENST00000320816.11 [P98082-1] ENST00000339788.10 [P98082-2] ENST00000509337.5 [P98082-3] D6REB1 D6RIA5 D6RFF7 ENST00000515700.5 ENST00000507539.5 ENST00000545653.5 [P98082-3] ENST00000503513.5 ENST00000511792.5 P98082 |